OHSU Knight Cancer Institute: Prostatic Neoplasms trials

The registry lists 40 Prostatic Neoplasms studies with OHSU Knight Cancer Institute as lead sponsor. 3 are open to participants now and 15 have results posted.

Early Phase 1 1Phase 1 3Phase 2 21Phase 4 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate CancerRecruitingNCT07504835Not applicable
• EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
• Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVERecruitingNCT06011499Not applicable
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerTerminatedNCT06630325Phase 2Results posted
• GET FIT Prostate: A Randomized Controlled Exercise TrialCompletedNCT03741335Not applicableResults posted
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT02522715Phase 1/2Results posted
• Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate CancerTerminatedNCT02501759Not applicableResults posted
• Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideActive, not recruitingNCT02312557Phase 2Results posted
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide TherapyCompletedNCT02099864Phase 2Results posted
• Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01498978Phase 2Results posted
• Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With DocetaxelTerminatedNCT01253642Phase 2Results posted
• Sulforaphane in Treating Patients With Recurrent Prostate CancerCompletedNCT01228084Phase 2Results posted
• Docetaxel in Treating Patients With Relapsed Prostate CancerTerminatedNCT00482274Phase 2Results posted
• Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate CancerTerminatedNCT00459810Phase 2Results posted
• Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate CancerTerminatedNCT00321698Phase 1/2Results posted
• Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate CancerCompletedNCT00253643Not applicableResults posted
• Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00017563Phase 2Results posted
• Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate CancerWithdrawnNCT06528210Phase 2
• Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETActive, not recruitingNCT05722925Phase 4
• Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the ProstateSuspendedNCT05362032Not applicable
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerCompletedNCT05012813Not applicable
• Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerActive, not recruitingNCT04267887Phase 2
• Exercising Together During Radiation TreatmentCompletedNCT03418025Not applicable
• Internet-Based Exercise and Diet Support in Prostate Cancer SurvivorsCompletedNCT03406013Not applicable
• Computer-Based Behavior Change Guide in Increasing Physical Activity in Patients With Prostate Cancer Who Have Received Androgen Deprivation TherapyCompletedNCT02869412Not applicable
• Pre-Prostatectomy Celecoxib or PlaceboTerminatedNCT02840162Phase 2
• Contrast Enhanced MRI of the ProstateCompletedNCT02245282
• Molecular Features and Pathways in Predicting Drug Resistance in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideCompletedNCT02228265
• Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01913015Phase 1
• Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerCompletedNCT01780701
• Exercise for Physical Health in Men With Prostate CancerCompletedNCT00660686Not applicable
• Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate CancerWithdrawnNCT00244920Phase 2
• Acupuncture in Treating Hot Flashes in Patients With Prostate CancerTerminatedNCT00244894Not applicable
• Flu/TBI in Treating Patients Not Responding to Previous Hormone TherapyWithdrawnNCT00242931Phase 2
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerCompletedNCT00182741Phase 2
• Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00017576Phase 2
• Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate CancerCompletedNCT00004043Phase 2
• Docetaxel in Treating Patients With Stage IV Prostate CancerCompletedNCT00003781Phase 2